The aim of this study is to investigate tasimelteon vs. placebo on sleep disturbances of individuals with Smith-Magenis Syndrome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To determine the efficacy of tasimelteon administered daily compared to placebo, as measured by improvement in sleep parameters
Timeframe: 9 Weeks